How to read the evidence.

Research Rats is not a protocol site. Every page is written to help you understand a compound’s mechanism, the strength of the evidence, the uncertainty around it, and the safety boundary — so you can read any claim critically. Here is the order that gets you there fastest.

1. 01

   Start with the Public Safety Preview

   On every premium page a free panel — “What to know before reading further” — states the evidence, safety, regulatory and claim-boundary context. Safety is never behind the gate.

2. 02

   Read the EvidenceProfile

   Where a compound is modelled, eight independent axes describe the state of the evidence. Read them together; no single axis settles the question.

3. 03

   Follow the mechanism and research-area links

   These connect related compounds so you can see how a pathway behaves across the literature, rather than judging it from one page in isolation.

4. 04

   Treat the headline as a description, not an instruction

   The one-line summary describes where the evidence stands today. It is not advice — and premium depth exists to explain the evidence, not to tell anyone what to do.

For modelled compounds we describe the evidence using the Research Rats Evidence System (RRES): eight independent axes, each rated on its own 0–4 scale. They are shown separately and never added up. A single number would invite the reading “higher means use this” — which is exactly what an honest evidence model must avoid.

• Each axis is separate. A strong mechanism says nothing about human evidence; strong human evidence says nothing about regulatory concern. Ratings are not comparable across axes.
• Safety is never averaged away. Safety characterisation measures how well the human safety profile is understood — not how safe a compound is. A well-characterised profile can still include serious known risks.
• There is no overall score, grade, or ranking. The headline is a human-written sentence that carries the nuance a set of bars cannot — never a figure you could rank one compound against another with.

See the method behind the ratings on the How we review evidence page.

A plausible biological mechanism explains how a compound could work. That is a reason to investigate — it is not evidence that it does work in people. Many compounds with elegant, well-supported mechanisms have no demonstrated clinical benefit.

On a Research Rats page, mechanistic plausibility and human evidence are deliberately separate axes for this reason: mechanism does not establish a clinical outcome, and a strong mechanism never upgrades weak human data.

Preclinical work — cell cultures and animal studies — can be genuinely valuable for understanding biology and prioritising research. But most compounds that work in rodents never replicate in people, so preclinical findings do not establish human outcomes. When a page’s evidence stops at animals, that gap is the most important part of the story, not a footnote.

Even within human evidence, the strength varies enormously:

Every premium compound page carries a free Public Safety Preview above the membership gate. It sets out four things in neutral language: what the evidence shows and where it stops, the key safety limitations and unknowns, the regulatory status, and where commercial or community claims can exceed the evidence — plus a fixed reminder that the page is educational and non-prescriptive.

• Communities are good at surfacing questions worth investigating and at flagging adverse experiences early.
• Popularity, confident testimonials, and before/after stories are not evidence of an effect — they are shaped by placebo, selection, and survivorship bias.
• An approved medical use is not a general wellness endorsement: the same compound used outside its studied indication is, in evidence terms, unstudied.

Research Rats lists popularly-claimed uses so you can test them against the data — listing a claim is not the same as endorsing it.

Research Rats is evidence-neutral: we explain the evidence landscape without steering you toward or away from any compound. To hold that line, the site does not provide:

• ×dosing, protocols, cycles, titration, administration or injection guidance
• ×stacks, sourcing, vendor links, or where-to-buy information
• ×compound rankings, “best” lists, or “what should I take” answers
• ×personalised medical advice, diagnosis, or treatment recommendations

The aim is to leave you able to say: I understand the mechanism, the evidence quality, the uncertainty, and the safety boundary. What you do with that understanding is a decision for you and a qualified healthcare professional.

Disclaimer. For educational and research purposes only. Not medical advice. We do not sell peptides or compounds.